Search
Fate Therapeutics Inc
FATEAdd to Watchlist
2.470USD
0.0000.00%
Close 07-27 16:00（ET）Quotes delayed by 15 min
283.24MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-27The current institutional shareholding score of Fate Therapeutics Inc is 7.00, ranking 80 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 79.47%, representing a quarter-over-quarter decrease of 34.82%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 5.22M shares, representing 8.87% of shares outstanding, with 16.25% increase in holdings.
Institutional Shareholding
Shareholder Activity
Name
Shares Held
Chg %
Redmile Group, LLC
Wilshire Advisors LLC
BlackRock Institutional Trust Company, N.A.
Two Sigma Investments, LP
Johnson & Johnson Innovation-JJDC, Inc.
Acadian Asset Management LLC
Geode Capital Management, L.L.C.
1
2